Feel like you're still behind?
We get it, it's impossible to keep up. Unless you were getting our daily newsletter all week long.
I WANT TO KEEP UP!
I'd rather not be informed.
Biotech & Health
OpenAI’s rise isn’t just a business story — it’s an ideological one. On Equity, Karen Hao, author of Empire AI, explores how the cult of AGI has fueled a billion-dollar race, justified massive spending on compute and data, and blurred the line between mission and profit.
Feel like you're still behind?
We get it, it's impossible to keep up. Unless you were getting our daily newsletter all week long.
I WANT TO KEEP UP!
I'd rather not be informed.
Biotech & Health

One investor says Koah is "building the essential monetization layer for consumer AI."

Current and former OpenAI researchers seem torn over how the company's Sora app fits in with its broader mission.

How can a chatbot be so wrong — and sound so confident in its wrongness?

Like OpenAI CEO Sam Altman, Bret Taylor thinks we're in an AI bubble — but he doesn't sound too worried about it.

OpenAI and Microsoft say they reached a non-binding agreement on a revised partnership.

The competitive landscape of AI is changing in ways that undermine the advantages of the biggest AI labs.